{"id":247633,"date":"2026-09-16T08:00:27","date_gmt":"2026-09-16T02:30:27","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/icici-pru-healthcare-fund-direct-growth-review-2026\/"},"modified":"2026-09-16T08:00:27","modified_gmt":"2026-09-16T02:30:27","slug":"icici-pru-healthcare-fund-direct-growth-review-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/icici-pru-healthcare-fund-direct-growth-review-2026\/","title":{"rendered":"ICICI Pru Healthcare Fund- Direct Growth Review 2026: NAV, Returns, Portfolio &#038; Should You Invest?"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/mutual-funds\/icici-pru-healthcare-fund-g-direct-plan\">ICICI Pru Healthcare Fund- Direct Growth Plan<\/a> has a NAV of \u20b946 as of 15 Sep 2026 and a scheme AUM of \u20b96,995 Cr. Its 1-year, 3-year and 5-year returns are 6.34%, 21.91% and 15.77%, and the scheme carries a High Risk profile. Our view is that the fund has combined a strong medium-term track record with a weaker one-year phase, so it is best understood as a thematic healthcare fund rather than a steady all-weather equity option.<\/p>\n<p>The portfolio is heavily tilted toward healthcare names, led by large positions in Sun Pharmaceutical Industries Ltd. and Dr. Reddy&#39;s Laboratories Ltd. That concentration can help the fund reflect the healthcare theme clearly, but it also means returns may move differently from the broader market.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/icici-pru-healthcare-fund-direct-growth-review-2026\/#Quick_facts\" title=\"Quick facts\">Quick facts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/icici-pru-healthcare-fund-direct-growth-review-2026\/#Performance\" title=\"Performance\">Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/icici-pru-healthcare-fund-direct-growth-review-2026\/#Should_you_BUY_or_HOLD_ICICI_Pru_Healthcare_Fund\" title=\"Should you BUY or HOLD ICICI Pru Healthcare Fund-?\">Should you BUY or HOLD ICICI Pru Healthcare Fund-?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/icici-pru-healthcare-fund-direct-growth-review-2026\/#Peer_comparison\" title=\"Peer comparison\">Peer comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/icici-pru-healthcare-fund-direct-growth-review-2026\/#Portfolio_where_your_money_goes\" title=\"Portfolio: where your money goes\">Portfolio: where your money goes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/icici-pru-healthcare-fund-direct-growth-review-2026\/#Who_should_invest\" title=\"Who should invest\">Who should invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/icici-pru-healthcare-fund-direct-growth-review-2026\/#Tax_and_exit_load\" title=\"Tax and exit load\">Tax and exit load<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/icici-pru-healthcare-fund-direct-growth-review-2026\/#Frequently_asked_questions\" title=\"Frequently asked questions\">Frequently asked questions<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/icici-pru-healthcare-fund-direct-growth-review-2026\/#Bottom_line\" title=\"Bottom line\">Bottom line<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/icici-pru-healthcare-fund-direct-growth-review-2026\/#Explore_mutual_funds_with_Univest\" title=\"Explore mutual funds with Univest\">Explore mutual funds with Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/icici-pru-healthcare-fund-direct-growth-review-2026\/#RIA_disclosure\" title=\"RIA disclosure\">RIA disclosure<\/a><\/li><\/ul><\/nav><\/div>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Quick_facts\"><\/span>Quick facts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Particular<\/th>\n<th>Details<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>NAV<\/td>\n<td>\u20b946 as of 15 Sep 2026<\/td>\n<\/tr>\n<tr>\n<td>AUM<\/td>\n<td>\u20b96,995 Cr<\/td>\n<\/tr>\n<tr>\n<td>Expense Ratio<\/td>\n<td>1.03%<\/td>\n<\/tr>\n<tr>\n<td>Launch Date<\/td>\n<td>13 Jul 2018<\/td>\n<\/tr>\n<tr>\n<td>Min SIP<\/td>\n<td>\u20b9100<\/td>\n<\/tr>\n<tr>\n<td>Risk Category<\/td>\n<td>High Risk<\/td>\n<\/tr>\n<tr>\n<td>Benchmark<\/td>\n<td>Nifty 50<\/td>\n<\/tr>\n<tr>\n<td>Fund Category<\/td>\n<td>Equity<\/td>\n<\/tr>\n<tr>\n<td>Exit Load<\/td>\n<td>1% on or before 15D, Nil after 15D<\/td>\n<\/tr>\n<tr>\n<td>Fund Managers<\/td>\n<td>Dharmesh Kakkad<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The fund is managed by Dharmesh Kakkad.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 15 Sep 2026<\/small><\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Performance\"><\/span>Performance<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Period<\/th>\n<th>Fund return<\/th>\n<th>Benchmark return<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1M<\/td>\n<td>-2.27%<\/td>\n<td>-4.81%<\/td>\n<\/tr>\n<tr>\n<td>3M<\/td>\n<td>2.22%<\/td>\n<td>-3.63%<\/td>\n<\/tr>\n<tr>\n<td>1Y<\/td>\n<td>6.34%<\/td>\n<td>-8.27%<\/td>\n<\/tr>\n<tr>\n<td>3Y<\/td>\n<td>21.91%<\/td>\n<td>5.59%<\/td>\n<\/tr>\n<tr>\n<td>5Y<\/td>\n<td>15.77%<\/td>\n<td>5.58%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The fund has held up better than the benchmark across every period shown. The recent 1-month and 3-month figures are mixed, which tells us the short-term path has been uneven rather than one-directional. Even so, the fund still finished ahead of the benchmark over both periods, which points to relative resilience while broader market returns stayed soft.<\/p>\n<p>The 1-year figure is modest in absolute terms, but the benchmark was negative over the same stretch. That means the fund protected capital better than the index in a difficult year, though it did not produce a high absolute return. This kind of pattern is typical of a sector fund that can move through sharp upswings and pauses.<\/p>\n<p>The 3-year and 5-year figures are where the story improves materially. Both periods show the fund well ahead of the benchmark, which suggests the longer compounding pattern has been stronger than the market backdrop. The recent monthly softness does not erase that longer record, but it does remind us that the path can be choppy even when the multi-year outcome is favourable.<\/p>\n<p>Our view is that the fund\u2019s return profile is more compelling over longer holding periods than over short ones. Investors looking only at the latest month may see volatility; investors looking across several years will see a stronger multi-year outcome relative to the benchmark.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 15 Sep 2026<\/small><\/p>\n<section class=\"univest-mf-premium-cta\" style=\"margin:28px 0;padding:24px;border-radius:10px;border:1px solid #d8e3f0;background:#f7faff\">\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Should_you_BUY_or_HOLD_ICICI_Pru_Healthcare_Fund\"><\/span>Should you BUY or HOLD ICICI Pru Healthcare Fund-?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A fund&#8217;s past returns alone don&#8217;t tell you whether you should buy it today or continue holding it.<\/p>\n<p>The right decision depends on factors such as your current allocation, purchase price, risk profile, investment horizon and the role this fund plays in your overall portfolio.<\/p>\n<p><strong>Already holding ICICI Pru Healthcare Fund-? Thinking of investing now?<\/strong><\/p>\n<p><a href=\"https:\/\/univest.in\/mutual-funds\" style=\"font-weight:700;text-decoration:none\">Get your portfolio analysed for FREE by SEBI-registered Investment Adviser (RIA) through Univest MF Premium<\/a><\/p>\n<\/section>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Peer_comparison\"><\/span>Peer comparison<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Fund<\/th>\n<th>1Y return<\/th>\n<th>3Y return<\/th>\n<th>5Y return<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/icici-pru-healthcare-fund-g-direct-plan\">ICICI Pru Healthcare Fund Direct Growth Plan<\/a><\/td>\n<td>6.34%<\/td>\n<td>21.91%<\/td>\n<td>15.77%<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/icici-pru-strategic-metal-and-energy-equity-fof-g-direct-plan\">ICICI Pru Strategic Metal and Energy Equity FoF Direct Growth Plan<\/a><\/td>\n<td>69.16%<\/td>\n<td>37.12%<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/motilal-oswal-active-momentum-fund-g-direct-plan\">Motilal Oswal Active Momentum Fund Direct Growth Plan<\/a><\/td>\n<td>30.67%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/kotak-healthcare-fund-g-direct-plan\">Kotak Healthcare Fund Direct Growth Plan<\/a><\/td>\n<td>28.09%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/hdfc-pharma-and-healthcare-fund-g-direct-plan\">HDFC Pharma and Healthcare Fund Direct Growth Plan<\/a><\/td>\n<td>27.47%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/univest.in\/mutual-funds\/sbi-automotive-opportunities-fund-g-direct-plan\">SBI Automotive Opportunities Fund Direct Growth Plan<\/a><\/td>\n<td>27.05%<\/td>\n<td>Data not available<\/td>\n<td>Data not available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>This assessment is prepared by Uniapps Investment Adviser Pvt. Ltd. under SEBI Registered Investment Adviser registration INA000017639. On 1-year returns, the fund trails the strongest peer figures in the list, but that gap is less important than the fact that the peer set contains several much faster recent movers. The more useful comparison is on the longer horizon: the fund\u2019s 3-year return is visibly stronger than the benchmark and also stronger than the one peer with a 3-year figure available. Its 5-year return sits in a similar constructive range, which suggests the medium-term record has been steadier than the short-term snapshot.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 15 Sep 2026<\/small><\/p>\n<div class=\"univest-peer-login-cta\" style=\"margin:20px 0;padding:16px 18px;border:1px solid #d8e3f0;border-radius:8px;background:#f7faff\">\n<p style=\"margin:0\"><strong>Want to know more?<\/strong> <a href=\"https:\/\/univest.in\/user\/log-in\" style=\"font-weight:700;text-decoration:none\">Log in to Univest<\/a> for more mutual fund insights.<\/p>\n<\/div>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Portfolio_where_your_money_goes\"><\/span>Portfolio: where your money goes<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Holding<\/th>\n<th>Sector<\/th>\n<th>Weight<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Sun Pharmaceutical Industries Ltd.<\/td>\n<td>Healthcare<\/td>\n<td>12.31%<\/td>\n<\/tr>\n<tr>\n<td>DR. Reddy&#8217;S Laboratories Ltd.<\/td>\n<td>Healthcare<\/td>\n<td>8.26%<\/td>\n<\/tr>\n<tr>\n<td>Cipla Ltd.<\/td>\n<td>Healthcare<\/td>\n<td>5.76%<\/td>\n<\/tr>\n<tr>\n<td>Mankind Pharma Ltd.<\/td>\n<td>Healthcare<\/td>\n<td>5.21%<\/td>\n<\/tr>\n<tr>\n<td>Alkem Laboratories Ltd.<\/td>\n<td>Healthcare<\/td>\n<td>4.87%<\/td>\n<\/tr>\n<tr>\n<td>Divi&#8217;S Laboratories Ltd.<\/td>\n<td>Healthcare<\/td>\n<td>4.83%<\/td>\n<\/tr>\n<tr>\n<td>TREPS<\/td>\n<td>Cash &amp; Cash Equivalents and Net Assets<\/td>\n<td>4.78%<\/td>\n<\/tr>\n<tr>\n<td>Biocon Ltd.<\/td>\n<td>Healthcare<\/td>\n<td>4.68%<\/td>\n<\/tr>\n<tr>\n<td>Medplus Health Services Ltd<\/td>\n<td>Retailing<\/td>\n<td>4.15%<\/td>\n<\/tr>\n<tr>\n<td>Cohance Lifesciences Ltd.<\/td>\n<td>Healthcare<\/td>\n<td>4.08%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The top holding is Sun Pharmaceutical Industries Ltd. at 12.31%, which is large enough to matter on its own. After that, the weights step down fairly gradually, from 8.26% in the second holding to 4.08% in the tenth. That kind of spread suggests the fund is not driven by just one or two stocks, but the biggest positions can still have a noticeable influence on outcomes.<\/p>\n<p>The top 10 holdings account for approximately 58.93% of the portfolio, and the fund discloses 36 holdings in total. That means the visible core is meaningful, but there is still a longer tail beyond the largest positions. In our view, this structure may allow the fund to stay strongly tied to the healthcare theme while reducing dependence on a single name.<\/p>\n<p>The presence of cash-equivalent exposure through TREPS also adds a small stabilising element, though the portfolio remains clearly centred on healthcare companies. For investors, that means performance may be shaped more by sector-specific sentiment and stock selection than by broad market diversification.<\/p>\n<p>To see all holdings, visit the <a href=\"https:\/\/univest.in\/mutual-funds\/icici-pru-healthcare-fund-g-direct-plan\">ICICI Pru Healthcare Fund- Direct Growth Plan<\/a> page<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 15 Sep 2026<\/small><\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Who_should_invest\"><\/span>Who should invest<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This fund suits investors who can tolerate High Risk and are comfortable with a healthcare-heavy equity allocation. The return pattern points to a fund that can lag or pause over short stretches, even though its 3-year and 5-year outcomes have been stronger than the benchmark.<\/p>\n<p>We think the fund fits a longer investment horizon, where investors can absorb volatility and give the thematic exposure time to work. The main trade-off is clear: you get focused healthcare exposure and the possibility of stronger multi-year compounding, but you also accept sharper swings and less diversification than a broad market fund.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Tax_and_exit_load\"><\/span>Tax and exit load<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Holding period<\/th>\n<th>Tax rate<\/th>\n<th>Description<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Units held less than 1 year<\/td>\n<td>20%<\/td>\n<td>Short-term capital gains tax<\/td>\n<\/tr>\n<tr>\n<td>Units held more than 1 year<\/td>\n<td>12.5%<\/td>\n<td>Long-term capital gains tax<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Exit load applies as 1% on or before 15D, and nil after 15D. After the holding period, there is no exit load.<\/p>\n<p class=\"mf-source-date\"><small>Source data date: as of 15 Sep 2026<\/small><\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Frequently_asked_questions\"><\/span>Frequently asked questions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>What is the current NAV of ICICI Pru Healthcare Fund- Direct Growth Plan?<\/strong><br \/>Its NAV is \u20b946 as of 15 Sep 2026.<\/p>\n<p><strong>What are the fund\u2019s 1-year, 3-year and 5-year returns?<\/strong><br \/>The fund\u2019s returns are 6.34% over 1 year, 21.91% over 3 years and 15.77% over 5 years.<\/p>\n<p><strong>How has the fund performed against the benchmark?<\/strong><br \/>It has outperformed the benchmark across 1 month, 3 months, 1 year, 3 years and 5 years. The 3-year and 5-year gaps are especially meaningful because they show stronger longer-term compounding.<\/p>\n<p><strong>How does the fund compare with the peer funds shown here?<\/strong><br \/>Its 1-year return is lower than the faster-moving peer examples shown, but its 3-year return is stronger than the one peer in the table with a 3-year figure available. The shorter and longer horizons tell different stories.<\/p>\n<p><strong>What is the minimum SIP amount?<\/strong><br \/>The minimum SIP amount is \u20b9100.<\/p>\n<p><strong>Who manages the fund and what is its exit load?<\/strong><br \/>Dharmesh Kakkad manages the fund. The exit load is 1% on or before 15D and nil after 15D.<\/p>\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Bottom_line\"><\/span>Bottom line<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>ICICI Pru Healthcare Fund- Direct Growth Plan has a mixed short-term and stronger multi-year profile. Its recent return trend has been uneven, but the 3-year and 5-year figures remain ahead of the benchmark, which makes the longer record more relevant than the latest patch. The portfolio is clearly healthcare-focused, with a sizable lead position and a meaningful weight in the top holdings, so the fund may appeal to investors seeking thematic exposure and willing to accept High Risk and sharper volatility.<\/p>\n<p class=\"univest-posted-at\" style=\"font-size:14px;color:#666;margin:20px 0 8px\">Published on 16 September 2026 at 7:59 AM IST<\/p>\n<section class=\"univest-login-cta\" style=\"margin:28px 0;padding:24px;border-radius:10px;background:#eef5ff;border:1px solid #cddff7;text-align:center\">\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"Explore_mutual_funds_with_Univest\"><\/span>Explore mutual funds with Univest<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Review mutual fund data, compare performance and explore fund insights on Univest.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\" style=\"display:inline-block;padding:11px 20px;border-radius:6px;background:#1f4e79;color:#fff !important;text-decoration:none;font-weight:700\">Explore Univest<\/a><\/p>\n<\/section>\n<section class=\"univest-disclaimer\">\n<h2 style=\"font-weight:700\"><span class=\"ez-toc-section\" id=\"RIA_disclosure\"><\/span>RIA disclosure<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Mutual fund investments are subject to market risks. Read all scheme-related documents carefully before investing. This review is prepared by Uniapps Investment Adviser Pvt. Ltd. (earlier known as Uniapps Global Research Pvt. Ltd.) under SEBI Registered Investment Adviser registration INA000017639 for general informational purposes and is not personalized investment advice.<\/p>\n<\/section>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"InvestmentFund\",\"name\":\"ICICI Pru Healthcare Fund- Direct Growth Plan\",\"identifier\":\"icici-pru-healthcare-fund-g-direct-plan\",\"category\":\"Equity\",\"dateCreated\":\"13 Jul 2018\",\"isAccessibleForFree\":true,\"additionalProperty\":[{\"@type\":\"PropertyValue\",\"name\":\"NAV\",\"value\":46,\"valueReference\":\"as of 15 Sep 2026\"},{\"@type\":\"PropertyValue\",\"name\":\"AUM\",\"value\":\"6995 Cr\"},{\"@type\":\"PropertyValue\",\"name\":\"Expense Ratio\",\"value\":\"1.03\"},{\"@type\":\"PropertyValue\",\"name\":\"Benchmark\",\"value\":\"Nifty 50\"},{\"@type\":\"PropertyValue\",\"name\":\"1Y Return\",\"value\":6.34},{\"@type\":\"PropertyValue\",\"name\":\"3Y Return\",\"value\":21.91},{\"@type\":\"PropertyValue\",\"name\":\"5Y Return\",\"value\":15.77},{\"@type\":\"PropertyValue\",\"name\":\"Fund Managers\",\"value\":\"Dharmesh Kakkad\"}]}<\/script><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the current NAV of ICICI Pru Healthcare Fund- Direct Growth Plan?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Its NAV is \u20b946 as of 15 Sep 2026.\"}},{\"@type\":\"Question\",\"name\":\"What are the fund\u2019s 1-year, 3-year and 5-year returns?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The fund\u2019s returns are 6.34% over 1 year, 21.91% over 3 years and 15.77% over 5 years.\"}},{\"@type\":\"Question\",\"name\":\"How has the fund performed against the benchmark?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"It has outperformed the benchmark across 1 month, 3 months, 1 year, 3 years and 5 years. The 3-year and 5-year gaps are especially meaningful because they show stronger longer-term compounding.\"}},{\"@type\":\"Question\",\"name\":\"How does the fund compare with the peer funds shown here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Its 1-year return is lower than the faster-moving peer examples shown, but its 3-year return is stronger than the one peer in the table with a 3-year figure available. The shorter and longer horizons tell different stories.\"}},{\"@type\":\"Question\",\"name\":\"What is the minimum SIP amount?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The minimum SIP amount is \u20b9100.\"}},{\"@type\":\"Question\",\"name\":\"Who manages the fund and what is its exit load?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Dharmesh Kakkad manages the fund. The exit load is 1% on or before 15D and nil after 15D.\"}}]}<\/script><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"Organization\",\"name\":\"Uniapps Investment Adviser Pvt. Ltd.\",\"description\":\"SEBI Registered Investment Adviser INA000017639\"}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ICICI Pru Healthcare Fund- Direct Growth Plan has a \u20b946 NAV as of 15 Sep 2026, \u20b96,995 Cr AUM, and 1Y\/3Y\/5Y returns of 6.34%\/21.91%\/15.77%.<\/p>\n","protected":false},"author":38,"featured_media":247631,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3841],"tags":[],"class_list":["post-247633","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mutual-funds"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["247631"],"rank_math_title":["ICICI Pru Healthcare Fund Review 2026 | NAV &amp; Returns"],"rank_math_description":["ICICI Pru Healthcare Fund- Direct Growth Plan NAV is \u20b946 as of 15 Sep 2026; 1Y return is 6.34% and 3Y return is 21.91%."],"rank_math_focus_keyword":["ICICI Pru Healthcare Fund- Direct Growth Plan review"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/ICICI_Pru_Healthcare_Fund_Direct_Growth_Review_2026_NAV_Returns_Portfolio_Should_You_Invest_neutral.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/247633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=247633"}],"version-history":[{"count":0,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/247633\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/247631"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=247633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=247633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=247633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}